Intrinsiqq
Inspira Technologies Oxy B.H.N. Ltd. logo

Inspira Technologies Oxy B.H.N. Ltd. Financials

IINN

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$0$0$0$0$0
Cost of Revenue$0$0$0––
Gross Profit$0$0$0––
Total Operating Expenses$14$11$12––
Operating Income-$14-$11-$12-$15-$13
Non-Operating
Net Interest Expense––$0-$0-$0
Income Tax Expense$0$0$0$0$0
Net Income
Net Income-$13-$11-$11-$15-$17
Per Share Data
Revenue Per Share$0.02$0.00$0.00$0.00$0.00
EPS (Basic)-$1.09-$0.91-$0.93-$0.91-$3.24
EPS (Diluted)-$1.09-$0.91-$0.93-$0.91-$3.24
Shares Outstanding12.1M12.1M12.1M11.3M5.3M

Inspira Technologies Oxy B.H.N. (IINN) financials: revenue, profit and margins

Inspira Technologies Oxy B.H.N. (IINN) generated about $289,000.00 in revenue and -$13 million in net income (a -4,574.4% net margin) over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Inspira Technologies Oxy B.H.N.'s (IINN) revenue?+

Inspira Technologies Oxy B.H.N. generated about $289,000.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Inspira Technologies Oxy B.H.N. profitable?+

Inspira Technologies Oxy B.H.N. reported about -$13 million in net loss over the trailing twelve months, a net margin of roughly -4,574.4%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Inspira Technologies Oxy B.H.N.'s profit margins?+

Inspira Technologies Oxy B.H.N. runs a gross margin of about 0.7%, an operating margin of about -4,713.8%, a net margin of about -4,574.4%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How the market compares: How many US companies are profitable

Peers

Medical Devices · Pick stocks to compare with IINN

CompareIntrinsic value
RDHLRedHill Biopharma Ltd. American
$0.42+1.44%10
XLS.XSWXXlife Sciences AG
CHF 9.44+8.51%0
ALOPM.XPAROncodesign Precision Medicine
€0.26-0.38%41
GDTCCytoMed Therapeutics Ltd.
$0.89-2.31%20
QLIFE.XSTOQlife Holding AB
€0.07-4.81%0
ALNEV.XPARNeovacs S.A.
€0.09-4.78%40
ALHYG.XPARHybrigenics SA
€0.01+3.03%15
EVG.XLONEvgen Pharma PLC
£0.00+1.18%40

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IINN

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.